BeStock  
Stocks › Biotechnology › AGIO

Agios Pharmaceuticals AGIO

US equityMarket cap rank #2807Biotechnology
$27.60 −$1.16 (-4.03%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.60 0.00%
Open$28.01
Prev close$28.76
Day range$27.43 – $29.14
Volume776.2K
Market cap$1.65B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$55.39M+330.0% YoY
Operating profit-$77.16M+34.0% YoY
Net profit-$65.05M+37.1% YoY
Diluted EPS-$1.09+38.8% YoY
Free cash flow-$60.42M+32.6% YoY
Operating cash flow-$59.24M

Revenue, last 8 quarters

$10.7MDec '24$8.7MMar '25$12.5MJun '25$12.9MSep '25$20.0MDec '25$20.7MMar '26$44.7MJun '26$55.4MSep '26

Net profit, last 8 quarters

$-96.5MDec '24$-89.3MMar '25$-112.0MJun '25$-103.4MSep '25$-108.0MDec '25$-99.1MMar '26$-100.7MJun '26$-65.0MSep '26

Diluted EPS by quarter

-1.74Dec '24-1.55Mar '25-1.93Jun '25-1.78Sep '25-1.85Dec '25-1.69Mar '26-1.69Jun '26-1.09Sep '26

Free cash flow by quarter

$-134.1MDec '24$-112.3MMar '25$-88.0MJun '25$-89.7MSep '25$-97.3MDec '25$-119.7MMar '26$-83.5MJun '26$-60.4MSep '26

Annual revenue

$0.0FY20$0.0FY21$14.2MFY22$26.8MFY23$36.5MFY24$54.0MFY25

Profitability & balance sheet

Gross margin93.8%
Operating margin-297.7%
Net margin-264.8%
Return on equity-32.9%
Return on assets-30.4%
Return on invested capital-35.5%
Current ratio9.69
Liabilities / assets8.0%
Cash & investments$630.01M
Total debt$6.88M
Net cash (debt)$623.13M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $55.39M $44.75M $20.75M $54.03M $19.97M
Total Operating Revenue $55.39M $44.75M $20.75M $54.03M $19.97M
Cost of Revenue $2.53M $3.00M $1.32M $6.35M $1.88M
Gross Profit $52.86M $41.75M $19.43M $47.68M $18.09M
Operating Expense $130.02M $152.30M $129.45M $519.82M $139.67M
Selling and Admin Expenses $56.53M $51.55M $48.30M $180.28M $51.61M
Research & Development $73.49M $100.75M $81.15M $339.54M $88.06M
Operating Profit -$77.16M -$110.55M -$110.03M -$472.13M -$121.58M
Net Non-Operating Interest Income (Expense) $8.88M $9.73M $10.80M $56.38M $12.41M
Non-Operating Interest Income $8.88M $9.73M $10.80M $56.38M $12.41M
Other Income (Expense) $3.24M $119,000.00 $119,000.00 $1.96M $113,000.00
Special Income (Charges) $2.97M – – $0.00 $0.00
-Gain on Sale Of Business $2.97M – – $0.00 $0.00
Other Non-Operating Income (Expenses) $266,000.00 $119,000.00 $119,000.00 $1.96M $113,000.00
Pretax Profit -$65.05M -$100.70M -$99.11M -$413.80M -$109.06M
Net Profit -$65.05M -$100.70M -$99.11M -$412.78M -$108.04M
Profit from Continuing Operations -$65.05M -$100.70M -$99.11M -$412.78M -$108.04M
Net Income to Parent Company -$65.05M -$100.70M -$99.11M -$412.78M -$108.04M
Net Income to Common Stockholders -$65.05M -$100.70M -$99.11M -$412.78M -$108.04M
Basic EPS -$1.09 -$1.69 -$1.69 -$7.12 -$1.85
Diluted EPS -$1.09 -$1.69 -$1.69 -$7.12 -$1.85
Tax – – – -$1.02M -$1.02M

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.06B $1.11B $1.18B $1.30B $1.30B
Total Current Assets $752.10M $717.67M $834.84M $942.05M $942.05M
Cash and Cash Equivalents & Short-Term Investments $630.01M $617.58M $113.60M $854.43M $854.43M
-Cash and Cash Equivalents $128.55M $99.65M $113.60M $89.13M $89.13M
-Short Term Investments $501.46M $517.93M – $765.30M $765.30M
Receivables $32.90M $24.22M – $10.58M $10.58M
-Accounts Receivable $25.25M $20.11M $16.13M $10.58M $10.58M
-Other Receivables $7.64M $4.10M – – –
Inventory $37.84M $30.15M $35.09M $32.92M $32.92M
Other Current Assets $51.35M $45.72M $799.76M $44.13M $44.13M
Total Non-Current Assets $311.94M $390.76M $350.15M $355.17M $355.17M
Net PPE $30.85M $33.82M – $41.23M $41.23M
-Gross PPE $30.85M $33.82M – $101.34M $101.34M
Investments and Advances $277.01M $347.25M – $310.01M $310.01M
-Available for Sale Securities $277.01M $347.25M – $310.01M $310.01M
Other Non-Current Assets $4.08M $9.68M $350.15M $3.93M $3.93M
Total Liabilities $84.70M $82.40M $75.88M $104.11M $104.11M
Total Current Liabilities $77.59M $70.22M $58.85M $82.21M $82.21M
Payables $19.93M $16.35M – $18.36M $18.36M
-Accounts Payable $19.93M $16.35M $13.75M $18.36M $18.36M
Current Accrued Expenses $18.93M $19.90M $14.61M $18.20M $18.20M
Short-Term Debt and Capital Lease Obligation $19.65M $19.23M – $18.39M $18.39M
-Current Capital Lease Obligation $19.65M $19.23M $18.81M $18.39M $18.39M
Total Non-Current Liabilities $7.12M $12.19M $17.03M $21.91M $21.91M
Long Term Debt and Capital Lease Obligation $6.88M $11.95M $16.94M $21.82M $21.82M
-Long Term Capital Lease Obligation $6.88M $11.95M $16.94M $21.82M $21.82M
Other Non-Current Liabilities $240,000.00 $240,000.00 $17.03M $90,000.00 $90,000.00
Total Equity $979.34M $1.03B $1.11B $1.19B $1.19B
Stockholders' Equity $979.34M $1.03B $2.43B $1.19B $1.19B
Capital Stock $76,000.00 $76,000.00 $0.00 $75,000.00 $75,000.00
-Common Stock $76,000.00 $76,000.00 – $75,000.00 $75,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $2.61B $2.59B $2.57B $2.56B $2.56B
Retained Earnings -$826.56M -$761.52M -$802.49M -$561.71M -$561.71M
Less: Treasury Stock -$802.49M -$802.49M -$660.82M -$802.49M -$802.49M
Gains/Losses Not Affecting Retained Earnings -$4.29M -$1.80M – $2.19M $2.19M
-Accumulated Depreciation – – – -$60.12M -$60.12M
-Total Tax Payable – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$59.24M -$57.31M -$118.92M -$372.98M -$96.21M
Net cash flow from continuing operations -$59.24M -$57.31M -$118.92M -$372.98M -$96.21M
Net Income from Continuing Operations -$65.05M -$100.70M -$99.11M -$412.78M -$108.04M
Gain/Loss from Continuing Operations $0.00 -$67,000.00 -$28,000.00 -$113,000.00 -$417,000.00
Depreciation & Depletion & Amortization $1.45M $1.35M $1.36M $5.18M $1.27M
Other Non-Cash Items $3.39M $28.32M $3.26M $22.43M $3.20M
Change in Working Capital -$14.78M -$1.03M -$38.80M -$33.04M -$4.59M
-Change in Receivables -$8.68M -$8.08M -$5.56M -$6.47M -$5.55M
-Change in Inventory -$7.69M $4.94M -$2.17M -$5.30M -$886,000.00
-Change in Prepaid Assets -$26,000.00 -$4.89M -$2.46M -$3.17M -$945,000.00
-Change in Payables and Accrued Expense $6.26M $11.43M -$24.16M -$527,000.00 $7.10M
-Change in Other Current Liabilities -$4.64M -$4.42M -$4.46M -$17.57M -$4.31M
Net cash flow from investing $83.96M $40.21M $141.31M $377.18M $90.08M
Net Cash Flow from Continuing Investing Activities $83.96M $40.21M $141.31M $377.18M $90.08M
Net PPE Purchase and Sale -$1.18M -$1.21M -$769,000.00 -$4.32M -$1.12M
Net Intangibles Purchase and Sale $0.00 – – -$10.00M $0.00
Net Investment Purchase and Sale $85.14M $66.42M $142.08M $391.50M $91.20M
Financing Cash Flow $4.18M $3.15M $2.08M $8.68M $2.56M
Net Cash Flow from Continuing Financing Activities $4.18M $3.15M $2.08M $8.68M $2.56M
Proceeds from Stock Option Exercised $4.18M $3.15M $2.08M $8.68M $2.56M
Ending Cash Balance $128.55M $99.65M $113.60M $89.13M $89.13M
Net Change in Cash $28.90M -$13.95M $24.47M $12.88M -$3.58M
Beginning Cash Balance $99.65M $113.60M $89.13M $76.25M $92.71M
Free Cash Flow -$60.42M -$83.52M -$119.69M -$387.29M -$97.33M
Net Business Purchase and Sale – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on AGIO.

Sign in to join the discussion.

Scroll to Top